Wintech Nano (Suzhou) Co., Ltd. (SHA:688757)

Market Cap	11.10B
Revenue (ttm)	437.06M
Net Income (ttm)	84.11M
Shares Out	403.31M
EPS (ttm)	0.23
PE Ratio	120.79
Forward PE	n/a
Dividend	0.15 (0.54%)
Ex-Dividend Date	Jun 30, 2025

Volume	3,632,553
Average Volume	3,511,768
Open	28.00
Previous Close	27.90
Day's Range	27.48 - 28.91
52-Week Range	9.08 - 31.00
Beta	n/a
RSI	58.09
Earnings Date	Jul 24, 2025

About Revance Therapeutics

Wintech Nano (Suzhou) Co., Ltd. provides commercial laboratory services in the field of electronics and semiconductor in China and internationally. It provides solutions for failure analysis, non-destructive testing, electrical analysis, physical failure analysis, surface analysis, trace elemental analysis, chemical analysis, crystal analysis, pull/shear test, burn-in, reliability test, and destructive physical analysis device, as well as R&D services. The company also offers automotive-grade chip testing, material analysis, and other testing s...

• Industry: Semiconductors
• Sector: Technology
• Founded: 2004
• Employees: 548
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688757

Financial Performance

In 2024, Wintech Nano (Suzhou)'s revenue was 415.27 million, an increase of 5.40% compared to the previous year's 393.98 million. Earnings were 81.18 million, a decrease of -17.61%.